FDA药品溶出方法数据库
(FDA-Recommended Dissolution Methods Database)
药品通用名称 剂型 USP溶出装置 速度 溶出介质 介质体积 建议取样时间(分钟) 更新日期
Zolmitriptan Tablet Refer to FDA's Dissolution Guidance, 2018 2020/07/02
Zolpidem Tartrate Tablet Refer to FDA's Dissolution Guidance, 2018 2020/07/02
Zolpidem Tartrate Tablet (Extended Release) Refer to USP 2012/01/05
Zolpidem Tartrate (1.75 and 3.5 mg) Tablet (Sublingual) II (Paddle) 50 Simulated intestinal fluid (without enzyme), pH 6.8, (deaerated) 500 1, 3, 5, 7, 10 and 15 2014/08/14
Zolpidem Tartrate (5 and 10 mg) Tablet (Sublingual) II (Paddle) 75 Phosphate Buffer, pH 6.8 900 1, 3, 5, 7, 10 and 15 2014/08/14
Zonisamide Capsule Develop a dissolution method 2023/09/15
Zonisamide Suspension Develop a dissolution method 2025/06/23
Zuranolone Capsule II (Paddle) with sinker 75 50 mM Sodium Phosphate Buffer, pH 6.8, w/ 0.3% SDS 900 10, 20, 30 and 45 2025/06/23

数据库说明:

当前数据更新日期:2025年09月06日。
©2006-2025 DrugFuture->FDA-Recommended Dissolution Methods Database